Long COVID may harm cognition

New research published in the New England Journal of Medicine reveals that Long COVID could potentially trigger declines in thinking and cognitive abilities. The study involved cognitive testing on 113,000 people in England, showing that those with Long COVID scored lower on IQ tests compared to those who had never been infected. Even those who…

Read More

Multiple Myeloma in Black and Hispanic Communities

Doctors and scientists have made significant progress in treating multiple myeloma, a type of blood cancer. While advancements have helped people live longer and healthier lives, there are disparities in care among different racial and ethnic groups. Multiple myeloma is more common in Hispanic and Black populations, who also tend to have a less serious…

Read More

Oral Herpes Tied to Double Dementia Risk in Older Adults

A study found that a history of herpes simplex virus (HSV) doubles the risk of dementia in older adults. The study followed 1002 individuals aged 70 over 15 years and found that 7% developed dementia. Anti-HSV IgG positivity was associated with a higher risk of dementia, but not Alzheimer’s disease. Treatment for herpes virus did…

Read More

Early Death, Heart Disease, And Cancer

Researchers conducted an extensive review linking ultra-processed food to 32 health issues, including diabetes, heart disease, mental health problems, cancer, and premature death. These foods undergo industrial processes and contain additives like sugar, fat, and salt. They make up a significant portion of daily energy intake in high-income countries and have become more common in…

Read More

Cancer Biotech Lands $145M for First-in-Class Drug to Block Elusive Tumor Target

FogPharma, a biotech company based in Cambridge, Massachusetts, has secured $145 million in funding for the clinical development of their novel therapeutic candidate for solid tumors. The drug, FOG-001, targets the Wnt/beta-catenin signaling pathway, which is linked to various types of cancer. The company’s unique peptide drugs, called Helicon therapeutics, are designed to penetrate cells…

Read More

Almost 12,000 doctors working in Irish public hospitals

A Key Trends report for Ireland shows a 57% increase in the number of hospital doctors employed in the public health service by 2022, with over 11,800 doctors working in public hospitals. The report also reveals a decrease in mortality rates for diseases such as cancer, circulatory system diseases, ischaemic heart diseases, and respiratory system…

Read More